| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.0076 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |